The Committees Split: Why Members Voted Yes or No The case made by yes voters Members supporting inclusion focused on clinical need, patient autonomy, professional judgment, and product quality
ended with big news as the FDA granted traditional approval to the first anti-amyloid antibodyand the first disease-altering drugfor Alzheimers disease
The published literature investigates cagrilintide as a tool compound in amylin and calcitonin-receptor signalling and in metabolic-pathway model systems
100% hypoallergenic, cruelty free & paraben free
J.Ayalon-DangurI.Ayalon-DangurR.NaamanyE.Gafter-GviliA.KorenG.et al (2019)
In fact, a Breakthrough T1D-funded researcher named Pauline Kay Lund, Ph.D., was the first to discover GLP-1 and GLP-2